Quotation

FreeSlate doomed

"FreeSlate builds upon a tradition of enabling scientific R&D organizations to accelerate the pace of discovery while reducing costly, complex procedures that hinder efficiency," said John Senaldi, FreeSlate's chief executive officer.

Another Pfizer Phase III program goes bust

How many more of these late stage clinical trials that have been promoted as helping Pfizer to avert the Liptor cliff will Pfail? Per Freddy Mercury..."and another ones gone, and another ones gone, another one bites the dust."

1,200 jobs go with AstraZeneca closure

AROUND 1,200 jobs are to be lost with the closure of one of Loughborough's biggest employers.

AstraZeneca today announced it is to shut its pharmaceutical plant in the town next year.

Staff were told this afternoon.

Loughborough MP Andy Reed said: "The word devastating is over used but I think that is the only way to describe this."

PFE Sandwich

Get shot of FTES and let the lab space!

Peakdale Molecular Partners With Pfizer
Drug Discovery & Development - February 01, 2010

Spectrum and Topotarget

Spectrum buying into cancer drug which is potential blockbuster. Not cheap, but probably worth it...

Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trial
•Belinostat, a HDAC Inhibitor, is Currently in a Multicenter, Registrational Trial Under a Special Protocol Assessment for Peripheral T-Cell Lymphoma (PTCL)

Lucifer at it again! Life Tech Denies Breach-of-Contract Claims in Suit by Former Visigen CEO

Life Technologies last week denied all allegations in a lawsuit that former Visigen Biotechnologies CEO and co-founder Susan Hardin filed in October 2009 against Life Tech, its Invitrogen unit, and Visigen, alleging breach of contract, fraud, negligent representation, and breach of fiduciary duty regarding Invitrogen's 2008 acquisition of Visigen.

Row over `haste' in allowing Ph.D seminar

Row over `haste' in allowing Ph.D seminar

Yogindra Mohan
PATIALA. The Punjabi University here seems set to create a record of sorts by allowing a research scholar to present his pre-thesis submission seminar for grant of a doctorate degree within three months of his registration in the Department of Biotechnology.

Pfizer / Wyeth what's going on?

I have heard that the first week of October is when the deal will be sealed. Day 1 will be 30 days later.